Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.73
BDXA's Cash-to-Debt is ranked lower than
94% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. BDXA: 0.73 )
Ranked among companies with meaningful Cash-to-Debt only.
BDXA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.2 Max: 1.03
Current: 0.73
0.03
1.03
Equity-to-Asset 0.34
BDXA's Equity-to-Asset is ranked lower than
82% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. BDXA: 0.34 )
Ranked among companies with meaningful Equity-to-Asset only.
BDXA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.47 Max: 0.63
Current: 0.34
0.25
0.63
Debt-to-Equity 1.51
BDXA's Debt-to-Equity is ranked lower than
89% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. BDXA: 1.51 )
Ranked among companies with meaningful Debt-to-Equity only.
BDXA' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.23  Med: 0.61 Max: 2
Current: 1.51
0.23
2
Interest Coverage 2.45
BDXA's Interest Coverage is ranked lower than
85% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.83 vs. BDXA: 2.45 )
Ranked among companies with meaningful Interest Coverage only.
BDXA' s Interest Coverage Range Over the Past 10 Years
Min: 2.45  Med: 15.87 Max: 42.29
Current: 2.45
2.45
42.29
Piotroski F-Score: 6
Altman Z-Score: 2.48
Beneish M-Score: -2.71
WACC vs ROIC
7.16%
6.91%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 9.29
BDXA's Operating Margin % is ranked higher than
77% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.15 vs. BDXA: 9.29 )
Ranked among companies with meaningful Operating Margin % only.
BDXA' s Operating Margin % Range Over the Past 10 Years
Min: 9.29  Med: 19.61 Max: 22.75
Current: 9.29
9.29
22.75
Net Margin % 6.51
BDXA's Net Margin % is ranked higher than
70% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. BDXA: 6.51 )
Ranked among companies with meaningful Net Margin % only.
BDXA' s Net Margin % Range Over the Past 10 Years
Min: 6.51  Med: 15.56 Max: 18.49
Current: 6.51
6.51
18.49
ROE % 8.66
BDXA's ROE % is ranked higher than
81% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.37 vs. BDXA: 8.66 )
Ranked among companies with meaningful ROE % only.
BDXA' s ROE % Range Over the Past 10 Years
Min: 8.66  Med: 24.34 Max: 28.17
Current: 8.66
8.66
28.17
ROA % 2.89
BDXA's ROA % is ranked higher than
58% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.13 vs. BDXA: 2.89 )
Ranked among companies with meaningful ROA % only.
BDXA' s ROA % Range Over the Past 10 Years
Min: 2.89  Med: 11.79 Max: 14.79
Current: 2.89
2.89
14.79
ROC (Joel Greenblatt) % 21.07
BDXA's ROC (Joel Greenblatt) % is ranked higher than
80% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.96 vs. BDXA: 21.07 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
BDXA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.07  Med: 35.48 Max: 40.37
Current: 21.07
21.07
40.37
3-Year Revenue Growth Rate 12.40
BDXA's 3-Year Revenue Growth Rate is ranked higher than
80% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.80 vs. BDXA: 12.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
BDXA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.4  Med: 8.4 Max: 12.4
Current: 12.4
4.4
12.4
3-Year EBITDA Growth Rate 8.50
BDXA's 3-Year EBITDA Growth Rate is ranked higher than
60% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. BDXA: 8.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
BDXA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11  Med: 8.5 Max: 32.2
Current: 8.5
-11
32.2
3-Year EPS without NRI Growth Rate -1.30
BDXA's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. BDXA: -1.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
BDXA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -14.2  Med: 10.6 Max: 21.9
Current: -1.3
-14.2
21.9
GuruFocus has detected 9 Warning Signs with Becton, Dickinson and Co $BDXA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» BDXA's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

BDXA Guru Trades in

BDXA Guru Trades in

BDXA Guru Trades in

Q2 2017

BDXA Guru Trades in Q2 2017

Howard Marks 822,700 sh (New)
George Soros 200,660 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with BDXA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2017-06-30 New Buy0.24%$52.08 - $54.75 $ 54.542%200,660
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Becton, Dickinson and Co

SymbolPriceYieldDescription
BDXA54.540.00

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:BAX, NAS:ILMN, NYSE:BCR, NYSE:MTD, NYSE:WAT, NAS:XRAY, NYSE:COO, NYSE:RMD, NAS:HOLX, NYSE:WST, NYSE:HRC, NAS:ICUI, NYSE:CMD, NAS:PODD, NYSE:HAE, NYSE:HYH, NAS:MMSI, NAS:NXTM, NAS:OSUR, NAS:ATRI » details
Traded in other countries:BOX.Germany, BDX.Switzerland, 0R19.UK,
Headquarter Location:USA
Becton, Dickinson and Co is a healthcare company. Its primary products include medical devices, instrument systems and reagents used by healthcare institutions.

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for 60% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps and ventilators), as well as procedural solutions businesses. The Bard deal gives the firm presence in urology, vascular and oncology.

Ratios

vs
industry
vs
history
PE Ratio 55.57
BDXA's PE Ratio is ranked lower than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. BDXA: 55.57 )
Ranked among companies with meaningful PE Ratio only.
BDXA' s PE Ratio Range Over the Past 10 Years
Min: 10.27  Med: 19.46 Max: 58.83
Current: 55.57
10.27
58.83
PE Ratio without NRI 55.57
BDXA's PE Ratio without NRI is ranked lower than
56% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. BDXA: 55.57 )
Ranked among companies with meaningful PE Ratio without NRI only.
BDXA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.02  Med: 20.98 Max: 58.83
Current: 55.57
13.02
58.83
Price-to-Owner-Earnings 96.98
BDXA's Price-to-Owner-Earnings is ranked higher than
58% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.16 vs. BDXA: 96.98 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
BDXA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.59  Med: 17.91 Max: 102.65
Current: 96.98
10.59
102.65
PB Ratio 3.50
BDXA's PB Ratio is ranked lower than
70% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.29 vs. BDXA: 3.50 )
Ranked among companies with meaningful PB Ratio only.
BDXA' s PB Ratio Range Over the Past 10 Years
Min: 2.96  Med: 4.06 Max: 5.6
Current: 3.5
2.96
5.6
PS Ratio 3.48
BDXA's PS Ratio is ranked lower than
52% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.24 vs. BDXA: 3.48 )
Ranked among companies with meaningful PS Ratio only.
BDXA' s PS Ratio Range Over the Past 10 Years
Min: 1.99  Med: 2.75 Max: 3.69
Current: 3.48
1.99
3.69
Price-to-Free-Cash-Flow 31.43
BDXA's Price-to-Free-Cash-Flow is ranked higher than
64% of the 70 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.92 vs. BDXA: 31.43 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
BDXA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.39  Med: 19.78 Max: 35.09
Current: 31.43
13.39
35.09
Price-to-Operating-Cash-Flow 19.92
BDXA's Price-to-Operating-Cash-Flow is ranked higher than
65% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.25 vs. BDXA: 19.92 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
BDXA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.75  Med: 12.45 Max: 21.08
Current: 19.92
8.75
21.08
PEG Ratio 18.67
BDXA's PEG Ratio is ranked lower than
91% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. BDXA: 18.67 )
Ranked among companies with meaningful PEG Ratio only.
BDXA' s PEG Ratio Range Over the Past 10 Years
Min: 0.92  Med: 1.83 Max: 27.81
Current: 18.67
0.92
27.81
Shiller PE Ratio 35.11
BDXA's Shiller PE Ratio is ranked higher than
69% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.16 vs. BDXA: 35.11 )
Ranked among companies with meaningful Shiller PE Ratio only.
BDXA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.19  Med: 24.84 Max: 39.76
Current: 35.11
17.19
39.76
Current Ratio 5.56
BDXA's Current Ratio is ranked lower than
83% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. BDXA: 5.56 )
Ranked among companies with meaningful Current Ratio only.
BDXA' s Current Ratio Range Over the Past 10 Years
Min: 1.14  Med: 1.92 Max: 5.82
Current: 5.56
1.14
5.82
Quick Ratio 5.01
BDXA's Quick Ratio is ranked lower than
86% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. BDXA: 5.01 )
Ranked among companies with meaningful Quick Ratio only.
BDXA' s Quick Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.23 Max: 5.1
Current: 5.01
0.7
5.1
Days Inventory 103.58
BDXA's Days Inventory is ranked higher than
68% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.43 vs. BDXA: 103.58 )
Ranked among companies with meaningful Days Inventory only.
BDXA' s Days Inventory Range Over the Past 10 Years
Min: 103.39  Med: 120.58 Max: 127.55
Current: 103.58
103.39
127.55
Days Sales Outstanding 52.51
BDXA's Days Sales Outstanding is ranked higher than
73% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.12 vs. BDXA: 52.51 )
Ranked among companies with meaningful Days Sales Outstanding only.
BDXA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.31  Med: 58.29 Max: 62.16
Current: 52.51
47.31
62.16

Buy Back

vs
industry
vs
history
3-Year Dividend Growth Rate 10.10
BDXA's 3-Year Dividend Growth Rate is ranked higher than
57% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. BDXA: 10.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
BDXA' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 2.6  Med: 11.7 Max: 29.1
Current: 10.1
2.6
29.1
3-Year Average Share Buyback Ratio -3.20
BDXA's 3-Year Average Share Buyback Ratio is ranked higher than
52% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.00 vs. BDXA: -3.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
BDXA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2  Med: 1.3 Max: 6.1
Current: -3.2
-3.2
6.1

Valuation & Return

vs
industry
vs
history
Forward Rate of Return (Yacktman) % 7.37
BDXA's Forward Rate of Return (Yacktman) % is ranked lower than
54% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.23 vs. BDXA: 7.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
BDXA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 5  Med: 13.95 Max: 19.6
Current: 7.37
5
19.6

More Statistics

Short Percentage of Float0.00%
52-Week Range $50.20 - 57.21

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}